Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Director | August 12, 2026 | August 13, 2026 |
| Inotiv, Inc.NOTVQ · Entity 29609 | Director | July 19, 2026 | July 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date August 12, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 131,451 |
Reported balance
After 2026-08-12 transaction · row 1
1 source rowRow 1 · 2026-08-12 · Purchase · Acquired 5,000 · Balance 131,451 |
Inotiv, Inc.
Report date July 19, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-19 transaction · row 1
1 source rowRow 1 · 2026-07-19 · Other · Disposed 76,892 · Balance 0 F1: The Amended Joint Prepackaged Chapter 11 Plan of Reorganization of Inotiv, Inc. and its Affiliated Debtors (the "Plan") under Chapter 11 of the Bankruptcy Code was confirmed by the United States Bankruptcy Court for the Southern District of Texas, Houston Division, on July 14, 2026, and became effective on July 19, 2026. On the effective date of the Plan, all outstanding common shares and other equity interests of Inotiv, Inc. were canceled for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: The Amended Joint Prepackaged Chapter 11 Plan of Reorganization of Inotiv, Inc. and its Affiliated Debtors (the "Plan") under Chapter 11 of the Bankruptcy Code was confirmed by the United States Bankruptcy Court for the Southern District of Texas, Houston Division, on July 14, 2026, and became effective on July 19, 2026. On the effective date of the Plan, all outstanding common shares and other equity interests of Inotiv, Inc. were canceled for no consideration.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date January 02, 2020 · Filed January 06, 2020
Section 16 reporting ended · disclosed 2020-01-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 59,500 |
Reported balance
After 2019-10-24 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-10-24 · Gift · Disposed 3,000 · Balance 59,500 F1: Reporting person disclaims beneficial ownership of these shares. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2021-01-02 | Direct | 1,608 |
Reported balance
After 2020-01-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-01-02 · Grant · Acquired 1,608 · Balance 1,608 F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 452 |
Reported balance
Holding disclosure · report date 2020-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 452 |
| Common StockSEC Table I · non-derivative | Direct | 47,800 |
Reported balance
Holding disclosure · report date 2020-01-02 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 47,800 |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2026 Filed Aug 13, 2026 20:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 5,000 | $21.82 | $109,100.00 |
DisclosureSEC source: 0001566340-26-000006 · form4-08132026_080847.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,451 Read SEC document |
| July 19, 2026 Filed Jul 20, 2026 20:31 UTC | Inotiv, Inc. NOTVQ · Entity 29609 | OtherCommon Stock | 76,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001566340-26-000004 · form4-07202026_080734.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The Amended Joint Prepackaged Chapter 11 Plan of Reorganization of Inotiv, Inc. and its Affiliated Debtors (the "Plan") under Chapter 11 of the Bankruptcy Code was confirmed by the United States Bankruptcy Court for the Southern District of Texas, Houston Division, on July 14, 2026, and became effective on July 19, 2026. On the effective date of the Plan, all outstanding common shares and other equity interests of Inotiv, Inc. were canceled for no consideration. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:44 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 12,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001566340-26-000002 · form4-05262026_080522.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,451 F2 · shares: Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:44 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001566340-26-000002 · form4-05262026_080522.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,255 F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 21:47 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001566340-25-000004 · form4-12022025_091237.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,577 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:08 UTC | Inotiv, Inc. NOTV · Entity 29609 | GrantCommon Stock | 39,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005696 · form4.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,892 F1 · shares: Represents a grant of restricted stock units which vest in full on March 14, 2026, or immediately prior to the next annual meeting of stockholders if stepping down from the Board. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 13:34 UTC | Inotiv, Inc. NOTV · Entity 29609 | PurchaseCommon Stock | 10,000 | $3.98 | $39,822.00 |
DisclosureSEC source: 0001062993-24-020292 · form4.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028159 · form4-12032024_101201.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,263 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 21:05 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,500 | $14.85 | $51,974.30 |
DisclosureSEC source: 0001415889-24-022238 · form4-08262024_090831.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,094 Read SEC document |
| August 10, 2024 Filed Aug 15, 2024 01:31 UTC | Inotiv, Inc. NOTV · Entity 29609 | GrantCommon Stock | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-015120 · form4.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 F1 · shares: Represents a grant of restricted stock units which vest in full on March 31, 2025, provided that the grantee continues to serve as a director of the Company through the vesting date. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,100 | $16.29 | $50,493.73 |
DisclosureSEC source: 0001415889-24-007631 · form4-03122024_080349.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,594 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:29 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015774 · form4-12042023_101219.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,494 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011978 · form4-12022022_101208.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,120 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010542 · edgar.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,471 F1 · shares: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 2,500 | $29.25 | $73,122.50 |
DisclosureSEC source: 0001179110-21-010542 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,164 Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 21:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,000 | $28.99 | $86,955.00 |
DisclosureSEC source: 0000950138-21-000412 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,684 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 23:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000505 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,684 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:34 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 4,000 | $23.84 | $95,360.00 |
DisclosureSEC source: 0000950138-20-000166 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,799 Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:01 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 1,608 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000002 · wf-form4_157834805509678.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,608 Underlying: Common Stock · 1,608 shares Expires 2021-01-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000571 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| October 24, 2019 Filed Jan 6, 2020 22:01 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000002 · wf-form4_157834805509678.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 59,500 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 17:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,000 | $116.72 | $1,867,520.00 |
DisclosureSEC source: 0000059478-19-000199 · wf-form4_155967100770907.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,300 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.36 to $117.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 22, 2019 Filed Aug 26, 2019 11:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,500 | $26.75 | $93,607.50 |
DisclosureSEC source: 0000950138-19-000468 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,283 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.74 to $26.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 21:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000244 · edgar.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783 F1 · price: Grant of deferred stock units to each of the non-employee members of the Issuer's Board of Directors, vesting three years from the date of grant. Read SEC document |
| February 11, 2019 Filed Jun 4, 2019 17:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000199 · wf-form4_155967100770907.xml · nonDerivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 62,500 F3 · kind: Bonafide gift of securities for the benefit of reporting persons spouse. Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 11, 2019 Filed Jun 4, 2019 17:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000199 · wf-form4_155967100770907.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,800 Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 00:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 18,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000055 · wf-form4_154949856017746.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,765 Underlying: Common Stock · 18,765 shares Expires 2020-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 04, 2019 Filed Feb 7, 2019 00:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 28,155 | $120.17 | $3,383,386.35 |
DisclosureSEC source: 0000059478-19-000055 · wf-form4_154949856017746.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,299 Read SEC document |
| February 04, 2019 Filed Feb 20, 2019 20:42 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 28,156 | $120.17 | $3,383,506.52 |
DisclosureSEC source: 0000059478-19-000106 · wf-form4a_155069532226405.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,300 F1 · shares: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 12,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,778 shares Expires 2019-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,404 | $119.86 | $527,863.44 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,144 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 23:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 12,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000038 · wf-form4_154941114595606.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2018 Filed Feb 1, 2019 18:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 1,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000014 · wf-form5_154904745815105.xml · nonDerivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,770 Read SEC document |
| June 12, 2018 Filed Feb 1, 2019 18:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000014 · wf-form5_154904745815105.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,032 Read SEC document |
| May 15, 2018 Filed Feb 1, 2019 18:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000014 · wf-form5_154904745815105.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,627 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:19 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 24,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000064 · wf-form4_151787272781244.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,524 shares Expires 2018-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:19 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 10,811 | $81.45 | $880,555.95 |
DisclosureSEC source: 0000059478-18-000064 · wf-form4_151787272781244.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,927 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:19 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 24,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000064 · wf-form4_151787272781244.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:13 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 12,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000054 · wf-form4_151744039642749.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,778 Underlying: Common Stock · 12,778 shares Expires 2019-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 23:13 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 16,158 | $87.60 | $1,415,440.80 |
DisclosureSEC source: 0000059478-18-000054 · wf-form4_151744039642749.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,214 Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 20:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 22,833 | $79.97 | $1,825,955.01 |
DisclosureSEC source: 0000059478-17-000159 · wf-form4_149703930291114.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,056 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $79.70 to $80.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,732 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,543 | $77.03 | $349,947.29 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,889 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:03 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 24,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000035 · wf-form4_148590381572425.xml · derivative · entry 3 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,524 Underlying: Common Stock · 24,524 shares Expires 2018-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:03 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 21,285 | $75.38 | $1,604,463.30 |
DisclosureSEC source: 0000059478-17-000035 · wf-form4_148590381572425.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,700 Read SEC document |
| March 01, 2016 Filed Jan 27, 2017 16:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000008 · wf-form5_148553445486764.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,415 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 9,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,066 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,194 | $79.10 | $331,745.40 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,915 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 9,066 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000296 · wf-form4_145452551565193.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.